Overview

An Investigational Drug in Patients With Osteoarthritis (0663-073)

Status:
Completed

Trial end date:
2003-11-13

Target enrollment:
0

Participant gender:
All

Summary

This study was conducted to assess the safety and tolerability of an investigational drug and to evaluate its effectiveness in the treatment of osteoarthritis of the hip or knee in both men and women.

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.

Treatments:

Etoricoxib
Ibuprofen

Criteria

Inclusion Criteria:

- Patients with osteoarthritis of the hip or knee who use current approved medication
(nonsteroidal anti-inflammatory drugs (NSAIDs)) or tylenol to treat the symptoms of
their osteoarthritis. Patients taking NSAIDs are required to discontinue using these
drugs and their symptoms must become worse.

Exclusion Criteria:

- Patients with certain medical conditions may not be allowed to participate. These
conditions will be reviewed with the study physician.